Shah, M., Chen, T., Ison, G., Fiero, M. H., Zhang, H., Gao, X., Neilson, M., Goldberg, K. B., Nair, A., Ricks, T. K., Pierce, W. F., Gormley, N., Theoret, M. R., Tang, S., Pazdur, R., Kluetz, P. G., Amiri-Kordestani, L. (2025). Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-02834